{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:59:49Z","timestamp":1795042789688,"version":"4.10.2"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI173064"],"award-info":[{"award-number":["R01AI173064"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijantimicag.2025.107633","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T04:22:17Z","timestamp":1758946937000},"page":"107633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacodynamic insights to support pneumonia treatment in a patient co-infected with two carbapenem-resistant bacteria"],"prefix":"10.1016","volume":"66","author":[{"given":"Brooke N.","family":"Curry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3155-9427","authenticated-orcid":false,"given":"Nidhi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9352-8389","authenticated-orcid":false,"given":"Alan E.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson V.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7131-3691","authenticated-orcid":false,"given":"Egon A.","family":"Ozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunkumar","family":"Karunanidhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayley","family":"Sherwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osayamen","family":"Obanor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahed","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5396-911X","authenticated-orcid":false,"given":"Zackery P.","family":"Bulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2025.107633_bib0001","series-title":"Antibiotic Resistance Threats in the United States, 2019","year":"2019"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054971","article-title":"Impact of carbapenem resistance on mortality in patients infected with Enterobacteriaceae: a systematic review and meta-analysis","volume":"11","author":"Zhou","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1231740","article-title":"Risk factors and outcome associated with coinfection with carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant pseudomonas aeruginosa or acinetobacter baumanii: a descriptive analysis","volume":"13","author":"Sophonsri","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0004","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ajic.2011.10.013","article-title":"Swimming in resistance\": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa","volume":"40","author":"Marchaim","year":"2012","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0005","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1086\/661597","article-title":"Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center","volume":"32","author":"Marchaim","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0006","article-title":"Clinical outcomes associated with co-infection of carbapenem-resistant enterobacterales and other multidrug-resistant organisms","volume":"4","author":"Tadese","year":"2022","journal-title":"Infect Prev Pract"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-215956","article-title":"Native valve Proteus mirabilis endocarditis: successful treatment of a rare entity formulated by in vitro synergy antibiotic testing","author":"Brotzki","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0008","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/23744235.2018.1533646","article-title":"Successful cure of daptomycin-non-susceptible, vancomycin-intermediate Staphylococcus aureus prosthetic aortic valve endocarditis directed by synergistic in vitro time-kill study","volume":"51","author":"Sumon","year":"2019","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0009","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jgar.2019.01.004","article-title":"Clinical relevance of in vitro synergistic activity of antibiotics for multidrug-resistant gram-negative infections: A systematic review","volume":"17","author":"Vardakas","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0010","article-title":"Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections","volume":"18","author":"Tamma","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0011","series-title":"Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-Ed34","year":"2024"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0012","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00692-21","article-title":"Generating genotype-specific aminoglycoside combinations with ceftazidime\/avibactam for KPC-producing Klebsiella pneumoniae","volume":"65","author":"Huang","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0013","year":"2013","journal-title":"Azactam (R) aztreonam injection [package insert]"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0014","unstructured":"Avycaz Package Insert. Allergan USA, Inc. Madison, NJ 2019."},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0015","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/cid\/cit334","article-title":"Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens","volume":"57","author":"Sandri","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0016","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1002\/cpbi.102","article-title":"Using SPAdes De Novo Assembler","volume":"70","author":"Prjibelski","year":"2020","journal-title":"Curr Protoc Bioinformatics"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91456-0","article-title":"AMRFinderPlus and the reference gene catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence","volume":"11","author":"Feldgarden","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0018","doi-asserted-by":"crossref","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","article-title":"Open-access bacterial population genomics: BIGSdb software, the PubMLST.Org website and their applications","volume":"3","author":"Jolley","year":"2018","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0019","unstructured":"CDC & FDA Antibiotic Resistance Isolate Bank. Atlanta (GA): CDC."},{"issue":"5","key":"10.1016\/j.ijantimicag.2025.107633_bib0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/antibiotics13050455","article-title":"Genomic characterization of carbapenemase-producing Enterobacter hormaechei, Serratia marcescens, Citrobacter freundii, Providencia stuartii, and Morganella morganii Clinical Isolates from Bulgaria","volume":"13","author":"Sabtcheva","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0021","unstructured":"Seeman T. Snippy v4.6.0. https:\/\/github.com\/tseemann\/snippy. Access date May 31, 2025"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0022","doi-asserted-by":"crossref","unstructured":"Wong TK, Ly-Trong N, Ren H, Ba\u00f1os H, Roger AJ, Susko E, et al. IQ-TREE 3: Phylogenomic inference software using complex evolutionary models. 2025.","DOI":"10.32942\/X2P62N"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0023","doi-asserted-by":"crossref","first-page":"W78","DOI":"10.1093\/nar\/gkae268","article-title":"Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool","volume":"52","author":"Letunic","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0024","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/jac\/dkaa345","article-title":"ResFinder 4.0 for predictions of phenotypes from genotypes","volume":"75","author":"Bortolaia","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0025","doi-asserted-by":"crossref","first-page":"D690","DOI":"10.1093\/nar\/gkac920","article-title":"CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database","volume":"51","author":"Alcock","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.ijantimicag.2025.107633_bib0026","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/antibiotics11060723","article-title":"Cefiderocol: Systematic review of mechanisms of resistance, heteroresistance and In vivo emergence of resistance","volume":"11","author":"Karakonstantis","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0027","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2164-9-75","article-title":"The RAST Server: rapid annotations using subsystems technology","volume":"9","author":"Aziz","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0028","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/jac\/dku322","article-title":"Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia","volume":"70","author":"Barber","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2020.115080","article-title":"A coup d'\u00e9tat by NDM-producing Klebsiella pneumoniae overthrows the major bacterial population during KPC-directed therapy","volume":"98","author":"Lenhard","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0030","doi-asserted-by":"crossref","first-page":"ciae403","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","volume":"7","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0031","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jgar.2023.08.010","article-title":"In vitro effectiveness of ceftazidime-avibactam in combination with aztreonam on carbapenemase-producing enterobacterales","volume":"35","author":"Romina","year":"2023","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0032","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1021\/acsinfecdis.6b00197","article-title":"Whole-cell-based assay to evaluate structure permeation relationships for carbapenem passage through the Pseudomonas aeruginosa porin OprD","volume":"3","author":"Iyer","year":"2017","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0033","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00039-22","article-title":"Impact of acquired broad-spectrum \u03b2-lactamases on susceptibility to cefiderocol and newly developed \u03b2-lactam\/\u03b2-lactamase inhibitor combinations in Escherichia coli and Pseudomonas aeruginosa","volume":"66","author":"Poirel","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0034","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1128\/JCM.01716-06","article-title":"Accuracies of beta-lactam susceptibility test results for Pseudomonas aeruginosa with four automated systems (BD Phoenix, MicroScan WalkAway, Vitek, and Vitek 2)","volume":"45","author":"Juretschko","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0035","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1038\/s41467-023-39416-2","article-title":"Mixed strain pathogen populations accelerate the evolution of antibiotic resistance in patients","volume":"14","author":"Diaz Caballero","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0036","series-title":"SENTRY Public Antimicrobial Surveillance Database","year":"2025"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107150","article-title":"Activity of cefiderocol and innovative \u03b2-lactam\/\u03b2-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double \u03b2-lactamases under high and low permeability conditions","volume":"63","author":"Blanco-Mart\u00edn","year":"2024","journal-title":"Int J Antimicrob Agents"},{"issue":"47","key":"10.1016\/j.ijantimicag.2025.107633_bib0038","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.47.2400587","article-title":"Genomic surveillance detects interregional spread of New Delhi metallo-beta-lactamase-1-producing Providencia stuartii in hospitals, Romania, December 2021 to September 2023","volume":"29","author":"Linkevicius","year":"2024","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijantimicag.2025.107633_bib0039","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1016\/S1473-3099(18)30093-8","article-title":"Clinical bacteriology in low-resource settings: today's solutions","volume":"18","author":"Ombelet","year":"2018","journal-title":"Lancet Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925001888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925001888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:49:50Z","timestamp":1780458590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925001888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0924857925001888"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107633","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamic insights to support pneumonia treatment in a patient co-infected with two carbapenem-resistant bacteria","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107633"}}